Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Brain Imaging01:14

Brain Imaging

Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans),  magnetic resonance imaging (MRI),  functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Video Quality on Video-Based Digital Assessment of Parkinson's Disease.

Digital biomarkers·2026
Same author

Smartphone-derived digital motor measures to monitor progression in idiopathic REM sleep behavior disorder.

NPJ Parkinson's disease·2026
Same author

Age-related changes to brain energetics revealed by PET/MRI imaging.

NeuroImage. Clinical·2026
Same author

A Novel Eigen-Volume-based Co-Activation Pattern Framework for Dynamic Functional Biomarkers of Multiple Sclerosis.

IEEE journal of biomedical and health informatics·2026
Same author

Rapid Profiling of EEG Responses to Non-Invasive Brain Stimulation in Parkinson's Disease: A Biomarker-Driven Screening Framework.

Biomedicines·2026
Same author

Exercise-Induced modulation of molecular-enriched functional connectivity in Parkinson's disease.

Journal of Parkinson's disease·2026

Related Experiment Video

Updated: Jul 5, 2026

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

Functional imaging in Parkinson disease.

R Nandhagopal1, Martin J McKeown, A Jon Stoessl

  • 1Pacific Parkinson's Research Center, University of British Columbia, Vancouver Hospital and Health Sciences Center, Purdy Pavilion, 2221 Wesbrook Mall, Vancouver, BC, Canada.

Neurology
|April 17, 2008
PubMed
Summary
This summary is machine-generated.

Functional imaging offers valuable insights into Parkinson disease (PD) mechanisms, assessing neurochemical changes and connectivity. These techniques aid in understanding motor and nonmotor symptoms, disease progression, and therapeutic responses in PD research.

More Related Videos

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

In vivo Positron Emission Tomography to Reveal Activity Patterns Induced by Deep Brain Stimulation in Rats
09:36

In vivo Positron Emission Tomography to Reveal Activity Patterns Induced by Deep Brain Stimulation in Rats

Published on: March 23, 2022

Related Experiment Videos

Last Updated: Jul 5, 2026

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

In vivo Positron Emission Tomography to Reveal Activity Patterns Induced by Deep Brain Stimulation in Rats
09:36

In vivo Positron Emission Tomography to Reveal Activity Patterns Induced by Deep Brain Stimulation in Rats

Published on: March 23, 2022

Area of Science:

  • Neuroimaging
  • Neurology
  • Radiochemistry

Background:

  • Parkinson disease (PD) involves complex neurochemical alterations and functional connectivity disruptions.
  • Understanding these changes is crucial for developing effective diagnostic and therapeutic strategies.

Purpose of the Study:

  • To review functional imaging techniques for assessing in vivo neurochemical alterations and functional connectivity in Parkinson disease (PD).
  • To explore the application of these imaging modalities in PD research.

Main Methods:

  • Radiotracer imaging with dopaminergic and other radiotracers to assess neurotransmitter function, metabolism, and blood flow.
  • Functional MRI (fMRI) using blood oxygen level dependent (BOLD) signal to detect neuronal activity.

Main Results:

  • Functional imaging aids in studying inflammation, compensatory mechanisms, and the neurobiological basis of motor/nonmotor complications in PD.
  • It helps understand dopaminergic transmission's role in behavioral processes and the placebo effect.
  • Current limitations include discordance between imaging and clinical outcomes, precluding use as surrogate endpoints in trials.

Conclusions:

  • Functional imaging provides insights into motor and nonmotor dysfunction mechanisms in PD.
  • These techniques show promise for studying the preclinical phase, surgical interventions, and neuroprotective strategies.